Hightop Health announced its acquisition of Marietta, Georgia-based Psych Atlanta on October 18. According to data captured in the LevinPro HC database, this transaction represents the 62nd Behavioral Health Care (BHC) acquisition of the year. This is a 33% decrease from last year, when there were 92 BHC transactions announced between January 1, 2022, and October 18, 2022.
Psych Atlanta is a mental health practice offering medication management, interventional psychiatry, ketamine, spravato and transcranial magnetic stimulation.
Backed by private equity firms JLL Partners and SV Health Investors, Hightop Health offers an outpatient mental health platform that uses an integrative and measurement-based approach to care.
According to the press release, Hightop plans to build out its Georgia market via a de novo strategy focused around Psych Atlanta. It also plans to develop new intensive outpatient programs and make a few other acquisitions in the Atlanta MSA area in the future. Financial terms of the deal were not disclosed.
